AITHENUTRIGENE CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9,840 KRW | -1.60% |
|
-5.11% | -24.19% |
| 2023 | AItheNutrigene Co., Ltd.'s Equity Buyback Plan Extended till December 21, 2023. | CI |
| 2022 | AItheNutrigene Co., Ltd. announces an Equity Buyback for KRW 2,000 million worth of its shares. | CI |
| 1 day | -1.60% | ||
| 1 week | -5.11% | ||
| Current month | -11.27% | ||
| 1 month | -12.92% | ||
| 3 months | -3.81% | ||
| 6 months | -2.57% | ||
| Current year | -24.19% |
1 week
9 260.00
10 500.00
1 month
9 260.0011 880.00
Current year
9 130.0014 000.00
1 year
9 130.0019 150.00
3 years
8 260.0029 300.00
5 years
8 260.0029 300.00
10 years
8 260.0029 300.00
| Managers | Title | Age | Since |
|---|---|---|---|
Jong-Cheol Kim
CEO | Chief Executive Officer | 54 | 28/02/13 |
Dong-Hoon Lee
CTO | Chief Tech/Sci/R&D Officer | 53 | 30/11/20 |
Su-Hwa Kim
BRD | Director/Board Member | 55 | 30/11/20 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Gyu-Jin Lee
BRD | Director/Board Member | 60 | - |
Jong-Cheol Kim
CEO | Chief Executive Officer | 54 | 28/02/13 |
Su-Hwa Kim
BRD | Director/Board Member | 55 | 30/11/20 |
AITheNutriGene Co is a Korea-based company primarily engaged in the development and provision of bio-healthcare platforms. The Company is engaged in the provision of personalized healthcare services that provide customized nutrition therapy according to the individual's genome. The Company is also engaged in the manufacture and sale of health functional foods and molecular diagnostic kits. In addition, the Company is also engaged in the provision of artificial intelligence (AI) solutions and consulting services.
| 1st Jan change | Capi. | |
|---|---|---|
| -24.19% | 22.52M | |
| +18.28% | 85.14B | |
| -27.47% | 72.06B | |
| +2.75% | 27.07B | |
| -9.55% | 17.43B | |
| -1.96% | 16.98B | |
| +3.53% | 16.02B | |
| +7.86% | 13.87B | |
| +70.71% | 13.06B | |
| +72.81% | 12.79B |
- Stock Market
- Equities
- A311960 Stock
